Today: 22 May 2026
Browse Category

IPO News 19 December 2025 - 9 January 2026

Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies India’s IPO share allotment is set for Jan. 9 after the offer drew 768 times subscription, with retail and non-institutional investors leading demand, BSE data showed. Shares are scheduled to list Jan. 13 on the BSE SME platform. Grey market prices hovered near 113 rupees, about 40% above the issue price, though this market is unregulated. The IPO was a fresh issue of 3.6 million shares at 76–81 rupees each.
9 January 2026
··
Baidu stock slides as Kunlunxin Hong Kong IPO plan shifts focus to timing, approvals

Baidu stock slides as Kunlunxin Hong Kong IPO plan shifts focus to timing, approvals

Baidu’s U.S. shares fell 3.7% to $144.75 Monday after its AI chip unit, Kunlunxin, filed for a Hong Kong listing and received exchange approval to proceed with a spin-off. Baidu said Kunlunxin will remain a subsidiary after the deal, but did not disclose offering size or timeline. Jefferies raised its Baidu price target to $181, estimating Kunlunxin’s valuation at up to $23 billion.
5 January 2026
···
Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds

Baidu shares jumped 14.9% to $150.30 after the company said it confidentially filed to spin off its AI chip unit, Kunlunxin, in a Hong Kong IPO. The stock touched $151.05 intraday, near a 52-week high. Baidu has not finalized offering details and said the deal depends on regulatory approval. Jefferies raised its price target to $181, estimating Kunlunxin’s value at up to $23 billion.
4 January 2026
··
Baidu stock jumps nearly 15% after AI chip unit Kunlunxin files for Hong Kong IPO

Baidu stock jumps nearly 15% after AI chip unit Kunlunxin files for Hong Kong IPO

Baidu’s U.S.-listed shares jumped 14.9% to $150.30 Friday after confirming its AI chip unit Kunlunxin filed confidentially for a Hong Kong listing. The spin-off remains subject to regulatory approvals and final terms. Traders are watching for updates on timing, valuation, and potential follow-through when U.S. markets reopen Monday.
4 January 2026
····
Baidu stock jumps nearly 15% on Kunlunxin IPO plan; what BIDU traders watch next

Baidu stock jumps nearly 15% on Kunlunxin IPO plan; what BIDU traders watch next

Baidu shares jumped 14.9% to $150.30 after the company said its AI chip unit Kunlunxin confidentially filed for a Hong Kong IPO. Baidu expects Kunlunxin to remain a subsidiary after the spin-off, but key terms are not finalized and the deal needs regulatory approval. Investors are watching for updates on IPO details and Baidu’s next earnings, expected around February 17, 2026.
3 January 2026
··
Nvidia’s China moat faces a new test as Biren pops 76% and Baidu chip unit files for Hong Kong IPO

Nvidia’s China moat faces a new test as Biren pops 76% and Baidu chip unit files for Hong Kong IPO

Shanghai Biren Technology surged 76% in its Hong Kong debut Friday, raising HK$5.58 billion after its IPO was heavily oversubscribed. Baidu said its AI chip unit Kunlunxin confidentially filed for a Hong Kong listing on Jan. 1. Samsung reported positive customer feedback for its HBM4 memory and is in talks to supply Nvidia. The U.S. granted TSMC an annual license to import chipmaking equipment to its Nanjing plant.
2 January 2026
·····
Firefly Aerospace stock steadies in premarket as lawsuit notice puts spotlight back on IPO claims

Firefly Aerospace stock steadies in premarket as lawsuit notice puts spotlight back on IPO claims

Firefly Aerospace shares dipped 0.1% to $23.34 premarket after a law firm announced a proposed securities class action tied to its August IPO. The lawsuit alleges Firefly overstated demand for its “Spacecraft Solutions” business and Alpha rocket program. Investors have until Jan. 12 to seek lead-plaintiff status. Firefly did not immediately comment.
29 December 2025
···
PMO sets 2030 deadline for Coal India’s subsidiary IPOs

PMO sets 2030 deadline for Coal India’s subsidiary IPOs

India’s Prime Minister’s Office has ordered the coal ministry to map and list all Coal India subsidiaries by 2030, sources told PTI. Bharat Coking Coal and Central Mine Planning & Design Institute are expected to list by March 2026, with IPO filings submitted to SEBI. Roadshows for Bharat Coking Coal have concluded. Coal India’s board has also approved listing processes for Mahanadi and South Eastern Coalfields.
29 December 2025
··
National Stock Exchange of India (NSE) Outlook: Nifty 50 Holds Near Record Highs as Year-End Data, F&O Expiry and IPO Buzz Take Center Stage

National Stock Exchange of India (NSE) Outlook: Nifty 50 Holds Near Record Highs as Year-End Data, F&O Expiry and IPO Buzz Take Center Stage

India’s Nifty 50 closed Friday at 26,042.30, down 0.38%, but posted a modest weekly gain, ending a three-week losing streak. Market capitalization of NSE-listed firms stood at about ₹471.58 lakh crore ($5.25 trillion) as of Dec. 26. Metals outperformed, while small-caps rose and mid-caps were flat. Trading volumes in December remained below November levels.
28 December 2025
··
Shanghai Stock Exchange Outlook: China’s 2026 Fiscal Signal, Yuan Strength, and STAR Market IPO Changes Set the Tone for the Next Session

Shanghai Stock Exchange Outlook: China’s 2026 Fiscal Signal, Yuan Strength, and STAR Market IPO Changes Set the Tone for the Next Session

The Shanghai Composite closed Friday at 3,963.68, up 0.1%, with turnover across Shanghai and Shenzhen at 2.16 trillion yuan. Gains in commercial spaceflight and lithium batteries offset broader weakness. Beijing signaled fiscal policy will be “more proactive” in 2026, aiming to boost consumption and investment. The yuan’s recent strength has eased foreign outflows and lifted market sentiment.
28 December 2025
···
Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining shares are trading near the mid-$40s after gold hit a record $4,420 per ounce, up two-thirds in 2025. The easing of geopolitical risks in Mali and a strategic overhaul are also driving the stock. Barrick’s 12-month range swung from the mid-teens to mid-$40s. Wall Street forecasts gold could reach $4,900/oz by late 2026.
22 December 2025
···
Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho shares fell about 6–7% to near ₹209–₹212 by midday Monday, December 22, after a sharp post-IPO rally that briefly pushed its market cap above ₹1 trillion. The stock has dropped roughly 8% over two sessions, reversing gains that saw it more than double from its ₹111 issue price after debuting on December 10. Traders cite profit-taking and limited supply as factors behind the volatility.
22 December 2025
··
National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

India’s NSE ended the week with the India VIX volatility index at a record low of 9.71 on December 18, signaling unusually calm equity markets despite record derivatives activity. Analysts say tighter regulations and strong domestic flows have curbed short-term speculation. The exchange’s IPO remains delayed amid ongoing governance issues. Option traders face shrinking premiums and fewer intraday opportunities.
21 December 2025
·
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

BioMarin agreed to acquire Amicus Therapeutics for $4.8 billion on Dec. 19, paying a 33% premium and adding two rare-disease drugs with $599 million in combined annual sales. The deal, plus an FDA approval for Cytokinetics and new IPO filings, drove biotech stocks higher ahead of the Christmas-shortened trading week. U.S. markets will close early Dec. 24 and remain shut Dec. 25.
21 December 2025
·····
Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

The Shanghai Composite Index closed Friday up 0.36% at 3,890.45, ending the week flat amid subdued trading and an earnings lull. November data showed industrial output growth slowed to 4.8% and retail sales rose just 1.3%, the weakest since late 2022. Property investment fell 15.9% year-to-date. The World Bank forecasts China’s 2025 growth at 4.9%, with further cooling expected in 2026.
21 December 2025
·
Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries shares closed at ₹1,565.10 on December 19, about 1% below their 52-week high, after rising 28% year-to-date. Market cap stands near ₹21.18 lakh crore. Morgan Stanley raised its target to ₹1,847, citing strong refining margins and new monetisation prospects. S&P Global upgraded Reliance’s credit profile, and Reuters reported progress toward a Jio IPO.
21 December 2025
····
Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

Morgan Stanley shares rose about 2.3% to $176.87 Friday, rebounding from a recent slide. The move followed a Reuters report naming the bank as a leading contender to manage a possible SpaceX IPO. Investors also focused on upbeat 2026 dealmaking forecasts and anticipation of Morgan Stanley’s fourth-quarter results in January. Intraday trading ranged from $173.07 to $177.54.
19 December 2025
···
1 2 3 4 5 … 7

Stock Market Today

  • Ceres Power Shares Surge 15% Amid Doosan Deal Speculation
    May 22, 2026, 4:51 AM EDT. Shares in Ceres Power Holdings PLC rose 15% following rumors of a potential deal with South Korean conglomerate Doosan. Ceres, known for its solid oxide fuel cell and electrolyser technology, saw increased investor interest as talks intensify. The partnership could accelerate commercialization and market penetration for Ceres' clean energy solutions, highlighting growing demand for sustainable technologies in the energy sector.

Latest articles

IBM Stock Gets a $1 Billion Quantum Jolt as Washington Bets Big

IBM Stock Gets a $1 Billion Quantum Jolt as Washington Bets Big

22 May 2026
IBM shares jumped 12.4% to $252.97 on Thursday after the company and the U.S. Commerce Department announced a proposed $1 billion award for a new quantum-chip foundry, Anderon. Trading volume reached 25.5 million shares, over five times Wednesday’s level. The funding is tied to definitive agreements and ongoing technical challenges in quantum computing.
D-Wave Shares Climb After $100 Million U.S. Quantum Deal Adds Washington as Shareholder

D-Wave Shares Draw Investor Interest After Washington Quantum Funding

22 May 2026
D-Wave Quantum traded near $28 in early premarket Friday after signing a letter of intent for $100 million in proposed U.S. funding, giving the Commerce Department an equity stake. Shares closed Thursday at $25.73, up 33.4%. The deal is not final and could be delayed or canceled. D-Wave reported $588.4 million in cash at March 31, with Q1 revenue down 81% to $2.9 million and a net loss of $18.4 million.
Rigetti Computing Stock Jumps Before RGTI Earnings as Quantum Revenue Test Hits Tonight

Rigetti Shares Rally Pre-Market After $100M U.S. Quantum Contract

22 May 2026
Rigetti shares rose 30.57% to $22.04 Thursday and traded at $24.10 pre-market Friday after the company signed a preliminary U.S. Commerce Department agreement for up to $100 million over three years. The deal is part of a $2 billion federal package for nine quantum firms, including equity stakes for the government.
Go toTop